Recall reminder issued for baby teething sticks after reports of continued sales
The strawberry apple flavor and banana flavor of the Soothe N Chew Teething Sticks were previously recalled because of a potential choking hazard for infants and young children, according to the FDA. Gerber has also since initiated a discontinuation of the product.
More Local News
The items were sold in stores nationwide and online. Those who purchased the products are advised to return them for a refund and contact a doctor if they're concerned about illness or injury.
Some consumers have reported choking incidents due to the product and at least one emergency room visit has been reported, according to the FDA's website.
More: Latest News from Around the Tri-State
A list of the recalled products can be found below.
Gerber Snacks for Baby soothe 'n' chew Teething Sticks, Strawberry Apple, Net Wt 3.2 Oz (90g), with UPC 0 15000 04618 7, all lot codes
Gerber Snacks for Baby soothe 'n' chew Teething Sticks, Banana, Net Wt 3.2 Oz (90g), with UPC 0 15000 04608 8, all lot codes
Gerber Snacks for Baby soothe 'n' chew Teething Sticks, Banana, Net Wt 1.58 Oz (45g), with UPC 0 15000 01015 7, all lot codes
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
4 hours ago
- Miami Herald
CVS, Target, Walmart: Which sell Plan B and/or the abortion pill?
Costco Wholesale has decided to not sell the abortion pill mifepristone across all its U.S. pharmacy stores, citing low demand. This isn't a change in policy or Costco (COST) dropping the medicine. It has never sold mifepristone in its warehouse clubs or through its pharmacies. "Our position at this time not to sell mifepristone, which has not changed, is based on the lack of demand from our members and other patients, who we understand generally have the drug dispensed by their medical providers," Costco said. The decision comes amid campaigns against the pill by religious activist groups, including Inspire Investing and Alliance Defending Freedom. Plan B (Levonorgestrel) Purpose: Emergency contraception to prevent pregnancy after unprotected sex or contraceptive failure (e.g., condom break). When used:Before a pregnancy starts, within 72 hours (best within 24 hours) after sex. How it works: Delays or prevents ovulation (egg release). May also prevent fertilization of the egg. Does not terminate an existing pregnancy. If the fertilized egg is already implanted, Plan B has no effect. Type: High-dose progestin (hormone), similar to birth control pill hormones, just in a single larger dose. Availability: Over-the-counter, no prescription, no age limit in the U.S. The Abortion Pill (Mifepristone + Misoprostol) Purpose: To end an existing pregnancy (up to about 10–11 weeks gestation in the U.S.). When used:After pregnancy has been confirmed (positive test or clinical confirmation). How it works:Mifepristone blocks progesterone, a hormone needed to maintain pregnancy. Misoprostol causes the uterus to contract and expel the pregnancy tissue. Type: Two different medications taken in sequence - not the same as hormonal birth control. Availability: Requires a prescription in the U.S. and is regulated under the FDA's Mifepristone REMS Program (dispensed at certified pharmacies, clinics, or by mail in states where legal). CVS: Stocked in most locations, typically in the family planning aisle; billing through insurance is possible, or pay out-of-pocket and claim later. You can also order online for Commonly available either on shelves or behind the counter; curbside and drive-thru pick-up may be offered Target: Carries Plan B both in-store and online, with options for delivery or same-day in-store Available in the family planning or sexual wellness section; online ordering with pickup or delivery options is also grocery and drugstore chains: Many large grocery store pharmacies (Kroger, Albertsons) and drugstore chains carry Plan B over-the-counter near other reproductive health retail pharmacies CVS and Walgreens: These two major chains have obtained FDA certification (through the Mifepristone REMS program) to dispense mifepristone in select locations, specifically in states where such dispensing is legally permitted. The list includes over 20 states such as California, New York, Illinois, Massachusetts, Pennsylvania, and others. However, availability varies by location and state-level restrictions Costco has said its decision on the abortion pill is a business one based on demand. The company generally stays out of politics. It has a very clear policy on its website: Costco Wholesale has a long-standing policy against making contributions to any political party or candidate, federal, state or local, in all countries in which we do business. This prohibition covers not only direct contributions, but also support through organizations created under section 527 of the Internal Revenue Code, buying tickets to political fundraising events, or furnishing goods, services, or equipment for political fundraising Company also prohibits contributions for "independent expenditures": communications that expressly advocate the election or defeat of a clearly identified candidate that are not made in cooperation, consultation, or concert with, or at the request or suggestion of, a candidate, candidate's authorized committee, or a political party. Related: Costco to keep abortion pill off shelves amid conservative outcry The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
7 hours ago
- Yahoo
Apple Watch Blood Oxygen Monitoring Is Back: Here's How to Get It
If you own a recent Apple Watch, you'll soon regain access to blood oxygen monitoring. Later today, owners of the Apple Watch Series 9, Series 10, and Ultra 2 will be able to download an update that revives the feature. On your iPhone, open the Watch app, tap General > Software Update, and look for watchOS 11.6.1. Also, go to Settings > General > Software Update and look for iOS 18.6.1. Once you've updated, check out our full rundown on what it can do and how to use it. In late 2023, sales of two Apple Watch models with blood oxygen monitoring were suspended after Apple lost a patent dispute. Masimo, a medical tech company, holds a patent describing hardware that measures bloody oxygen. It accused Apple of poaching Masimo employees to help develop its own blood oxygen sensors for the Apple Watch. Masimo sued in district court before bringing the issue to the International Trade Commission (ITC), which ruled in Masimo's favor. Apple issued a software update to turn the feature off and restart sales of the Series 9 and Ultra 2. By the time the Series 10 debuted last year, the dispute was still going on, so that smartwatch did not include the blood oxygen feature. Apple says it redesigned its blood oxygen feature, and that today's launch "was enabled by a recent US Customs ruling." Apple says this doesn't affect older iPhones with the original blood oxygen feature or Apple Watches purchased outside the US. This new update will allow you to start a Blood Oxygen monitoring session on the Apple Watch, and the data will sync with your iPhone. The Respiratory section within the Apple Health app will provide a full breakdown of the results.
Digital Trends
8 hours ago
- Digital Trends
The 2026 Apple Watch could get upgrades that I've been waiting for years
In just over a month, Apple will introduce the world to a fresh portfolio of iPhones. Rumors have focused on a camera-centric design overhaul for the 'Pro' flagships and a whole new ultra-slim sibling that will adopt the 'Air' branding. It sounds like this year's Apple Watch may not be a showstopper of the Fall launch event, but its successor might turn out to be one that I've been waiting for ages. According to supply chain outlet DigiTimes, the purported Apple Watch Series 12 set to arrive in 2026 could be a massive overhaul, both inside and outside. 'The high-end Apple Watch model launching in 2026 is expected to undergo substantial upgrades and redesigns centered around enhanced sensing capabilities,' says the report. Recommended Videos Citing multiple supply chain sources, the report mentions three key areas of improvement for the 2026 Apple Watch related to battery, biosensing, and aesthetics. Starting with the sensors, Apple reportedly plans to double the number of sensors on its smartwatch, going from four to eight. A big leap for on-wrist biosensing Supplied by TASC, the report notes that the sensors will be arranged in a ring-like shape on the underside, protected by a transparent glass cover. Aside from opening the doors for new health sensing capabilities, the new sensors will reportedly help improve battery efficiency, as well. Now, let's talk about the next-gen biosensing chops. Rumors suggest that blood pressure sensing will finally land on the Apple Watch this year, or next. Apple is most likely relying on the same light-based technique for assessing the blood pressure that we've already seen on Samsung's Galaxy smartwatches. This approach relies on calibration with a medical-grade sensor, while Huawei has developed a micropump system for its smartwatches that works standalone. Older reports claim that the Apple Watch won't tell absolute systolic/diastolic blood pressure values, but will simply warn users about any abnormal spikes or drops. Another promising wellness feature is non-invasive blood glucose level analysis. Apple has been working on the tech stack for years, but due to regulatory concerns and technical challenges, it hasn't served it aboard an Apple Watch, yet. The underlying tech, however, has been in development in other labs for years. In 2022, experts at Georgia's Kennesaw State University reported the development of a noninvasive system of blood glucose level measurement device called GlucoCheck that works in tandem with a mobile application. A year later, Movano revealed an AI-powered needle-free wearable that lets users check real-time glucose data. Michael Leabman, the company's CEO and founder, told Digital Trends that their smartwatch relies on an onboard radio frequency-powered sensor for the job. So far, no mainstream smartwatch brand has delivered on glucose analysis tech, and if Apple manages to pull it off, it would mark yet another huge leap for the company. What else is on the table? The DigiTimes report also hints at big gains in the battery life department. It notes that on the Apple Series 12, 'power efficiency will improve significantly.' I am more excited about this upgrade, which is supposedly made possible by shifting to a next-gen sensor hub. Over the past couple of years, smartwatches running Google's Wear OS software have made big strides in the battery life department. The OnePlus Watch 2 and its successor, owing to their unique dual-OS approach, can easily go past two days without losing any of their functional charm. Samsung's current generation Galaxy Watch 8 series smartwatches also last longer, and in my tests, they comfortably got past a day. With battery saving tools applied, while disabling always-on display and frugal background activity, I got a per-charge mileage close to a couple of days. Apple's smartwatches rarely go past a full day on a single charge. Finally, the 2026 Apple Watch is also said to be in line for a design makeover, a year ahead of a similar treatment planned for the anniversary edition iPhone. The report only mentions 'a significant redesign,' but doesn't go into details about any minute details. Since its market arrival, the Apple Watch has retained the same fundamental design, with the only notable changes being a slimming down of the chassis and the switch to a curved display. Apple is reportedly planning to add cameras to its smartwatch, but there is little clarity whether the 2026 Apple Watch will be the first to get it.
